Cite
Long-Term Use of Tamoxifen Is Associated With a Decreased Subsequent Meningioma Risk in Patients With Breast Cancer: A Nationwide Population-Based Cohort Study
MLA
Li-Min Sun, et al. “Long-Term Use of Tamoxifen Is Associated With a Decreased Subsequent Meningioma Risk in Patients With Breast Cancer: A Nationwide Population-Based Cohort Study.” Frontiers in Pharmacology, vol. 10, June 2019. EBSCOhost, https://doi.org/10.3389/fphar.2019.00674.
APA
Li-Min Sun, Cheng-Li Lin, Sean Sun, Chung Y. Hsu, Zonyin Shae, & Chia-Hung Kao. (2019). Long-Term Use of Tamoxifen Is Associated With a Decreased Subsequent Meningioma Risk in Patients With Breast Cancer: A Nationwide Population-Based Cohort Study. Frontiers in Pharmacology, 10. https://doi.org/10.3389/fphar.2019.00674
Chicago
Li-Min Sun, Cheng-Li Lin, Sean Sun, Chung Y. Hsu, Zonyin Shae, and Chia-Hung Kao. 2019. “Long-Term Use of Tamoxifen Is Associated With a Decreased Subsequent Meningioma Risk in Patients With Breast Cancer: A Nationwide Population-Based Cohort Study.” Frontiers in Pharmacology 10 (June). doi:10.3389/fphar.2019.00674.